
    
      An initial cohort of 6 participants will receive a single dose of one of two investigational
      pneumococcal vaccines. After safety evaluation of that cohort, additional cohorts will
      receive 2 injections 30 days apart of same investigational pneumococcal vaccine at same or
      increased dose level. All participants will be monitored for safety for 30 days after each
      vaccination.
    
  